Research ArticleDrug Discovery and Translational Medicine
Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643
Tatjana Momic
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Jehoshua Katzehendler
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Ofra Benny
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Adi Lahiani
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Gadi Cohen
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Efrat Noy
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Hanoch Senderowitz
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Johannes A. Eble
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Cezary Marcinkiewicz
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
Philip Lazarovici
School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (T.M., J.K., O.B., A.L., G.C., P.L.); Department of Bioengineering, College of Engineering, Temple University, Philadelphia, Pennsylvania (C.M.); Department of Chemistry, Bar Ilan University, Ramat-Gan, Israel (E.N., H.S.); Center for Molecular Medicine, Department of Vascular Matrix Biology, Frankfurt University Hospital, Excellence Cluster Cardio-Pulmonary System, Frankfurt, Germany (J.A.E.); and Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany (J.A.E.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleDrug Discovery and Translational Medicine
α1β1/α2β1 Peptide Antagonists with Antiangiogenic Activity
Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643
Research ArticleDrug Discovery and Translational Medicine
α1β1/α2β1 Peptide Antagonists with Antiangiogenic Activity
Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement